第一作者机构：[1]Hebei Univ, Affiliated Hosp, Dept Thorac Surg, Baoding 071000, Hebei, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Xuguang,Liu Rongfang.Neoadjuvant furmonertinib plus chemotherapy achieved pathologic complete response in a patient with EGFR-mutated lung adenocarcinoma[J].ASIAN JOURNAL OF SURGERY.2025,48(7):4208-4209.doi:10.1016/j.asjsur.2025.02.115.
APA：
Zhang, Xuguang&Liu, Rongfang.(2025).Neoadjuvant furmonertinib plus chemotherapy achieved pathologic complete response in a patient with EGFR-mutated lung adenocarcinoma.ASIAN JOURNAL OF SURGERY,48,(7)
MLA：
Zhang, Xuguang,et al."Neoadjuvant furmonertinib plus chemotherapy achieved pathologic complete response in a patient with EGFR-mutated lung adenocarcinoma".ASIAN JOURNAL OF SURGERY 48..7(2025):4208-4209
